Scleroderma, Localized: Clinical Trials

5 trials for Scleroderma, Localized, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 11Completed 1

Follow Scleroderma, Localized: new trials by email Literature Review of Scleroderma, Localized trials Research Report on Scleroderma, Localized

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
Dupilumab 300Mg Solution for Injection, Placebo - Localized Scleroderma
Phase 2CompletedUniversity of Cologne452020-05-192024-10-26
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
Crisaborole - Morphea
Phase 2CompletedDuke University82018-09-012021-04-01
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
Rituximab - Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
Phase 2CompletedUniversity Hospital, Ghent32009-06-012021-07-13
Efficacy and Safety of Imatinib in Scleroderma
imatinib mesylate - Scleroderma, Localized, Scleroderma, Systemic
Phase 2CompletedUniversity Hospital, Bordeaux282007-12-012026-05-14
Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
UVB Irradiation - Keloid, Scleroderma, Localized
Phase 1 / Phase 2CompletedUniversity of Michigan332002-08-012015-05-01

Narrower conditions

Scleroderma, Diffuse (2)  ·  Acne Keloid (1)  ·  Cicatrix (1)  ·  Eosinophilic Fasciitis (1)  ·  Granuloma Annulare (1)  ·  Keloid (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Connective Tissue Diseases (5)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Acneiform Eruptions (1)  ·  Collagen Diseases (1)  ·  Fibrosis (1)  ·  Folliculitis (1)  ·  Granuloma (1)  ·  Hair Diseases (1)  ·  Necrobiotic Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Scleroderma, Systemic (1)

Interventions

Imatinib Mesylate (1)  ·  Injections (1)  ·  Rituximab (1)  ·  Solutions (1)  ·  crisaborole (1)  ·  dupilumab (1)

Sponsors

Duke University (1)  ·  University Hospital, Bordeaux (1)  ·  University Hospital, Ghent (1)  ·  University of Cologne (1)  ·  University of Michigan (1)

Countries

United States (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)

Top investigators

Adela Cardones, MD (1)  ·  Filip De Keyser, MD, PhD (1)  ·  John J Voorhees, MD (1)  ·  Sabine Eming, Prof. Dr. (1)

Results publications

PMID 23039171

NIH funding

2019 (1)